Skip to Main Content

Paper Details

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Patient-Centered Outcomes From a Randomized Clinical Trial.
Am J Ophthalmol
28
2016
NEI, PATIENT, PDR, PRP, Patient, Proliferative Diabetic Retinopathy, Ranibizumab, participants, patient, patients, proliferative diabetic retinopathy, ranibizumab
Activities of Daily Living, Angiogenesis Inhibitors, Automobile Driving, Diabetic Retinopathy, Female, Humans, Intravitreal Injections, Laser Coagulation, Male, Middle Aged, Patient Outcome Assessment, Ranibizumab, Retinal Neovascularization, Sickness Impact Profile, Surveys and Questionnaires, Vascular Endothelial Growth Factor A, Visual Acuity, Work Performance
Author NameAffiliation
Wesley T BeaulieuJaeb Center for Health Research
Neil M BresslerWilmer Eye Institute, Johns Hopkins University School of Medicine
Michele MeliaJaeb Center for Health Research
Cynthia OwsleyUniversity of Alabama at Birmingham
Calvin E Mein
Jeffrey G Gross
Lee M JampolFeinberg School of Medicine, Northwestern University
Adam R GlassmanJaeb Center for Health Research
  • 1 - 8

Datasets

Release 1.2